top of page

Saturday, May 29, 2021

11:00am–1:00pm ET

For healthcare practitioners: the first Canadian conference on the current state of scleroderma therapy and research.

Opening Remarks & Welcome

Dr. Shafiq Qaadri (Moderator),

James Gamble

Dr. Shafiq Qaadri goes over the learning objectives and James Gamble, Country Medical Director of Mallincrokdt Pharmaceuticals, welcomes delegates to the 2021 Scleroderma Summit.

State of the Art Therapy for Scleroderma

Dr. Janet Pope

Dr. Janet Pope, Professor of Medicine at Schulich School of Medicine & Dentistry at University of Western Ontario, gives an overview of the state of therapy for Scleroderma in 2021.

Canada's Rare Drug Strategy

Dr. Durhane Wong-Rieger

Dr. Durhane Wong-Rieger, President of the Canadian Organization for Rare Disorders (CORD), discusses the strategy to a national rare diseases framework for Canada.

Access to Treatment: Industry Perspective

Lorraine Boyle

Lorraine Boyle, Managing Director of case Market Access Consulting Inc, goes over the industry perspective of rare disorder approaches.

Access to Treatment: Patient Perspective

Maureen Sauvé

Maureen Sauvé, Vice President, Advocacy & Public Relations of the Scleroderma Society of Ontario, details the patient perspective and challenges in diagnosing Scleroderma.

Live Panel Discussion

Dr. Shafiq Qaadri

A live panel discussion with Dr. Durhane Wong-Rieger, Dr. Robert Gniadecki, Lorraine Boyle and Maureen Sauvé.

Skin Signs for Systemic Sclerosis

Dr. Robert Gniadecki

Dr. Robert Gniadecki goes over lesions, skin changes, and pitfalls of systemic sclerosis.

Putting Patients in Touch with Support

John Malcolmson

John Malcolmson talks about Scleroderma Canada's mission to enrich the quality of life for scleroderma patients through advocacy, patient support, education and research.

Live Panel Discussion & Closing Remarks

Dr. Shafiq Qaadri

A live panel discussion with Dr. Durhane Wong-Rieger, Dr. Robert Gniadecki, Lorraine Boyle, Maureen Sauvé and John Malcolmson.

bottom of page